Firefighters say this antioxidant helped them - their union warns it could be risky
Glutathione, an antioxidant, has been offered as a treatment at some of the largest US wildfires in recent years.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
""I felt much better immediately after the worst exposure of my career.""
— David Marquez , Other
""We don't know if glutathione is effective.""
— Sean DeCrane , Other
""The lack of research really raised concerns for us.""
— Sean DeCrane , Other
Key People
David Marquez is a Pasadena Fire Captain with over 25 years of firefighting experience.
Jen Riegle is a co-founder of the Integrated Health Action Network and a licensed naturopath.
Sean DeCrane is the assistant to the general president for health and safety at the IAFF.
All Coverage
Glutathione, an antioxidant, has been offered as a treatment at some of the largest US wildfires in recent years.
Similar Stories
Related coverage based on topic and tags
Blood tests find high level of cancer-causing forever chemical in residents near factory
People living near a major chemical factory in Lancashire are told they could be at risk of serious health conditions.
September 23, 2026 at 09:01 PMTwo pilots die in helicopter crash fighting California wildfire - reuters.com
Two pilots die in helicopter crash fighting California wildfire reuters.com
September 21, 2026 at 11:37 PMWatch: How toxic smog from wildfires is making Indonesians sick
Around 175,000 people in Indonesia have suffered from respiratory illness since August.
September 23, 2026 at 03:46 PMUS FDA advisers endorse Grail cancer test's benefits in key vote - Reuters
US FDA advisers endorse Grail cancer test's benefits in key vote Reuters
September 23, 2026 at 11:03 PMNew hope for breast cancer patients as life-extending drug now on NHS in England
Enhertu, which can give patients an extra seven months to live on average, has been prescribed in Scotland for more than two years and is available.
September 16, 2026 at 11:50 PMMerck's drug for diabetes-related eye disease meets trial goal - Reuters
Merck's drug for diabetes-related eye disease meets trial goal Reuters
September 24, 2026 at 02:52 PM